DnB Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.5M Sell
46,655
-3,472
-7% -$1.82M 0.1% 151
2025
Q1
$31.8M Buy
50,127
+14,323
+40% +$9.08M 0.15% 115
2024
Q4
$25.5M Buy
35,804
+2,685
+8% +$1.91M 0.11% 145
2024
Q3
$34.8M Buy
33,119
+689
+2% +$724K 0.16% 112
2024
Q2
$34.1M Buy
32,430
+1,196
+4% +$1.26M 0.16% 104
2024
Q1
$30.1M Sell
31,234
-1,059
-3% -$1.02M 0.16% 109
2023
Q4
$28.4M Buy
32,293
+1,532
+5% +$1.35M 0.15% 119
2023
Q3
$25.3M Buy
30,761
+1,482
+5% +$1.22M 0.15% 117
2023
Q2
$21M Buy
29,279
+7,492
+34% +$5.38M 0.12% 138
2023
Q1
$17.9M Buy
21,787
+1,255
+6% +$1.03M 0.11% 149
2022
Q4
$14.8M Sell
20,532
-211
-1% -$152K 0.1% 169
2022
Q3
$14.3M Sell
20,743
-10,140
-33% -$6.99M 0.11% 165
2022
Q2
$18.3M Sell
30,883
-1,666
-5% -$985K 0.13% 144
2022
Q1
$22.7M Sell
32,549
-1,270
-4% -$887K 0.14% 136
2021
Q4
$21.4M Sell
33,819
-6,429
-16% -$4.06M 0.13% 147
2021
Q3
$24.4M Sell
40,248
-7,043
-15% -$4.26M 0.16% 122
2021
Q2
$26.4M Buy
47,291
+5,195
+12% +$2.9M 0.18% 111
2021
Q1
$19.9M Buy
42,096
+4,992
+13% +$2.36M 0.15% 122
2020
Q4
$17.9M Buy
37,104
+795
+2% +$384K 0.16% 122
2020
Q3
$20.3M Sell
36,309
-41,284
-53% -$23.1M 0.22% 86
2020
Q2
$48.4M Buy
77,593
+11,248
+17% +$7.01M 0.57% 36
2020
Q1
$32.4M Buy
66,345
+4,436
+7% +$2.17M 0.48% 40
2019
Q4
$23.2M Buy
61,909
+11,339
+22% +$4.26M 0.23% 80
2019
Q3
$14M Buy
50,570
+18,751
+59% +$5.2M 0.16% 111
2019
Q2
$9.96M Sell
31,819
-17,580
-36% -$5.5M 0.11% 141
2019
Q1
$20.3M Sell
49,399
-4,099
-8% -$1.68M 0.23% 80
2018
Q4
$20M Buy
53,498
+30,868
+136% +$11.5M 0.26% 79
2018
Q3
$9.14M Buy
+22,630
New +$9.14M 0.1% 144
2018
Q2
Sell
-26,400
Closed -$9.09M 637
2018
Q1
$9.09M Buy
26,400
+2,100
+9% +$723K 0.11% 141
2017
Q4
$9.14M Buy
+24,300
New +$9.14M 0.11% 137